Keybanc Maintains Overweight on Omnicell, Lowers Price Target to $65
Keybanc analyst Scott Schoenhaus maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $70 to $65.
Analyst Expectations for Omnicell’s Future
Over the past 3 months, 5 analysts have published their opinion on Omnicell (NASDAQ:OMCL) stock. These analysts are…
Piper Sandler Maintains Overweight on Omnicell, Raises Price Target to $66
Piper Sandler analyst Jessica Tassan maintains Omnicell (NASDAQ:OMCL) with a Overweight and raises the price target from $55 to $66.
Wells Fargo Maintains Overweight on Omnicell, Lowers Price Target to $65
Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $71 to $65.
JP Morgan Maintains Neutral on Omnicell, Lowers Price Target to $57
JP Morgan analyst Anne Samuel maintains Omnicell (NASDAQ:OMCL) with a Neutral and lowers the price target from $140 to $57.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 184 companies set new 52-week lows.
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Gainers
Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
Keybanc Maintains Overweight on Omnicell, Lowers Price Target to $75
Keybanc analyst Scott Schoenhaus maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $130 to $75.
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.